Author Question: A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. ... (Read 72 times)

tiara099 · **on:** Jul 23, 2018

A patient is undergoing a cytotoxic chemotherapy regimen for the treatment of stage III lung cancer. What effect will this regimen likely have on the patient's hemostatic function?

A) The patient's platelet count will decline.
B) The patient will be at increased risk of deep vein thrombosis.
C) The patient will require prophylactic heparin.
D) The patient will likely experience thrombocytosis.

Question 2

A patient is taking atorvastatin calcium (Lipitor) to reduce serum cholesterol. Which of the following aspects of patient teaching is most important?

A) Call his physician if he develops muscle pain
B) It is acceptable to eat saturated fats
C) Decrease the dose if lethargy occurs
D) Eat two eggs per day to increase protein stores

ecox1012 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

A
Feedback:
Thrombocytopenia is a common adverse effect of cytotoxic chemotherapy. Heparin is consequently contraindicated, and DVT is not a priority risk.

Answer to Question 2

A